Full-Time

Director – Global Regulatory Science

CMC

Posted on 9/10/2024

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines for health

Biotechnology
Healthcare

Senior, Expert

Norwood, MA, USA

Position based at the Norwood, MA site.

Category
Legal
Risk & Compliance
Legal & Compliance
Requirements
  • Bachelor’s degree in a scientific/engineering discipline
  • 12+ years of experience in the pharmaceutical/biotech industry
  • 8 + years of experience in Regulatory CMC
  • Strong knowledge of current Global CMC regulations, including with CTD format and content of CMC regulatory submissions
  • Strong knowledge of and broad experience with regulatory procedures and legislation related to CMC aspects for drug development, product registration, line extension and license maintenance
  • Ability to effectively collaborate in a dynamic, cross-functional matrix environment to drive meeting each program’s critical regulatory milestones
  • Prior management experience required
  • Exceptional written and oral communication
  • Bachelors Degree with 15 years of experience in the pharmaceutical/biotech industry
  • MS/PhD degree in Molecular Biology, Pharmaceutics, Chemistry, or closely related field is desirable
  • 10+ years of experience in the pharmaceutical/biotech industry, manufacturing and/or analytical focus
  • 8+ years of experience in Biologics focused Regulatory CMC
Responsibilities
  • Develop/implement effective CMC regulatory strategies for submissions (e.g. IND/CTA/BLA/MAA) and identify regulatory risks
  • Provide guidance for regulatory CMC aspects of product development projects
  • Review documents for submission-readiness, to ensure that all submissions conform to health authority guidelines
  • Lead Regulatory CMC discussions and interactions with health authorities to facilitate review and approval of submissions
  • Develop regulatory processes and procedures to support CMC components of regulatory submissions
  • Support the creation and maintenance of CMC submission templates
  • Provides CMC regulatory guidance to manufacturing and quality teams; evaluates CMC change controls
  • Perform assessment of manufacturing change controls
  • Provides interpretation of regulatory guidance documents, regulations, and directives – advises Manufacturing, Quality and Process/Analytical Development groups regarding their applicability and impact on internal programs
  • Lead oversight of multiple programs in various therapeutic areas (vaccines, oncology and/or rare diseases)

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a crucial component in how cells produce proteins necessary for various biological functions. Their approach involves creating a new class of medicines that utilize mRNA to instruct cells to produce specific proteins, potentially leading to significant advancements in treatment options for patients. Unlike traditional pharmaceuticals, which often rely on small molecules or proteins, Moderna's mRNA-based therapies aim to enhance the discovery, development, and manufacturing processes of medicines. The company's goal is to leverage the unique properties of mRNA to improve patient outcomes and create a new category of effective treatments.

Company Stage

IPO

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

2010

Growth & Insights
Headcount

6 month growth

4%

1 year growth

16%

2 year growth

55%
Simplify Jobs

Simplify's Take

What believers are saying

  • Opening a new vaccine facility in Victoria enhances manufacturing capabilities.
  • Strategic investment in China boosts Moderna's presence in the Asian market.
  • Collaboration with Carisma Therapeutics could lead to breakthroughs in autoimmune treatments.

What critics are saying

  • Potential removal from Nasdaq 100 could impact investor perception.
  • Reticence in Hong Kong for Covid-19 jab indicates market penetration challenges.
  • Expansion into China may expose Moderna to geopolitical and regulatory risks.

What makes Moderna unique

  • Moderna is pioneering mRNA technology for innovative medical treatments.
  • The company has a strong focus on developing vaccines for infectious diseases.
  • Moderna's mRNA platform enables rapid development of therapeutics and vaccines.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE